Thrivent Financial for Lutherans’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-62,051	Closed	-$465K	–	2589
2024 Q2	$465K	Sell	62,051 -2,650	-4%	-$19.9K	﹤0.01%	2249
2024 Q1	$645K	Buy	+64,701	New	+$645K	﹤0.01%	2120